Follow
Jonathan Sjögren
Jonathan Sjögren
Genovis
Verified email at genovis.com - Homepage
Title
Cited by
Cited by
Year
EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein
J Sjögren, WB Struwe, EFJ Cosgrave, PM Rudd, M Stervander, M Allhorn, ...
Biochemical journal 455 (1), 107-118, 2013
1242013
A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa
T Mohanty, J Sjögren, F Kahn, AHA Abu-Humaidan, N Fisker, K Assing, ...
Blood, The Journal of the American Society of Hematology 126 (18), 2128-2137, 2015
1132015
Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysis
J Sjögren, F Olsson, A Beck
Analyst 141 (11), 3114-3125, 2016
1002016
EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans
J Sjögren, EFJ Cosgrave, M Allhorn, M Nordgren, S Björk, F Olsson, ...
Glycobiology 25 (10), 1053-1063, 2015
892015
Deciphering Protein O-Glycosylation: Solid-Phase Chemoenzymatic Cleavage and Enrichment
S Yang, P Onigman, WW Wu, J Sjögren, H Nyhlen, RF Shen, J Cipollo
Analytical chemistry, 2018
872018
Structural basis of mammalian mucin processing by the human gut O-glycopeptidase OgpA from Akkermansia muciniphila
B Trastoy, A Naegeli, I Anso, J Sjögren, ME Guerin
Nature communications 11 (1), 4844, 2020
712020
Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence
J Sjögren, CYM Okumura, M Collin, V Nizet, A Hollands
BMC microbiology 11, 1-7, 2011
552011
Bacterial glycosidases in pathogenesis and glycoengineering
J Sjögren, M Collin
Future Microbiology 9 (9), 1039-1051, 2014
512014
EndoE from Enterococcus faecalis Hydrolyzes the Glycans of the Biofilm Inhibiting Protein Lactoferrin and Mediates Growth
J Garbe, J Sjögren, EFJ Cosgrave, WB Struwe, M Bober, AI Olin, ...
PLoS One 9 (3), e91035, 2014
492014
On enzymatic remodeling of IgG glycosylation; unique tools with broad applications
J Sjögren, R Lood, A Nägeli
Glycobiology 30 (4), 254-267, 2020
412020
Optimization of O-GIG for O-Glycopeptide Characterization with Sialic Acid Linkage Determination
S Yang, WW Wu, R Shen, J Sjogren, L Parsons, JF Cipollo
Analytical Chemistry 92 (16), 10946-10951, 2020
242020
State-of-the-art native mass spectrometry and ion mobility methods to monitor homogeneous site-specific antibody-drug conjugates synthesis
E Deslignière, A Ehkirch, BL Duivelshof, H Toftevall, J Sjögren, ...
Pharmaceuticals 14 (6), 498, 2021
222021
Glycan-mediated technology for obtaining homogeneous site-specific conjugated antibody–drug conjugates: synthesis and analytical characterization by using complementary middle …
BL Duivelshof, E Deslignière, O Hernandez-Alba, A Ehkirch, H Toftevall, ...
Analytical chemistry 92 (12), 8170-8177, 2020
212020
EndoSd: An IgG Glycan Hydrolyzing Enzyme in Streptococcus Dysgalactiae Subspecies Dysgalactiae
A Shadnezhad, A Naegeli, J Sjögren, B Adamczyk, F Leo, M Allhorn, ...
Future Microbiology 11 (6), 721-736, 2016
212016
Antibody conjugations via Glycosyl remodeling
H Toftevall, H Nyhlén, F Olsson, J Sjögren
Antibody-Drug Conjugates: Methods and Protocols, 131-145, 2019
142019
Turning universal O into rare Bombay type blood
I Anso, A Naegeli, JO Cifuente, A Orrantia, E Andersson, ...
Nature Communications 14 (1), 1765, 2023
112023
Generating and purifying Fab fragments from human and mouse IgG using the bacterial enzymes IdeS, SpeB and Kgp
J Sjögren, L Andersson, M Mejàre, F Olsson
Bacterial Pathogenesis: Methods and Protocols, 319-329, 2016
102016
Endoglycosidase from Streptococcus pyogenes and methods using it
M Collin, M Allhorn, J Sjögren
US Patent 9,493,752, 2016
52016
Multiple modes of action mediate the therapeutic effect of intravenous IgG in experimental epidermolysis bullosa acquisita
E Pipi, A Kasprick, H Iwata, S Goletz, JE Hundt, H Sadeghi, ...
Journal of Investigative Dermatology 142 (6), 1552-1564. e8, 2022
42022
Treatment for IgE-mediated disease
M Collin, R Lood, K Carlstrom, M Allhorn, J Sjogren, F Nimmerjahn, ...
US Patent App. 14/002,949, 2012
3*2012
The system can't perform the operation now. Try again later.
Articles 1–20